We are live on ! Find out more
BCDA icon

BioCardia
BCDA

8 hedge funds and large institutions have $2.62M invested in BioCardia in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.03% less ownership

Funds ownership: 0.63% → 0.6% (-0.03%)

8% less capital invested

Capital invested by funds: $2.85M → $2.62M (-$229K)

33% less funds holding

Funds holding: 12 → 8 (-4)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
8
Holders Change
-4
Holders Change %
-33.33%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
+$6.52K
2
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$474

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$58K
2
Millennium Management
Millennium Management
New York
-$41K
3
Jane Street
Jane Street
New York
-$35K
4
TRCT
Tower Research Capital (TRC)
New York
-$6K
5
Bank of America
Bank of America
North Carolina
-$364

BCDA Hedge Fund Activity: Q3 2020 in Review

8 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q3 2020, worth a combined $2.62M — down 8% from $2.85M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BCDA and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Osaic Holdings, adding an estimated $6.52K. The largest seller was CVI Holdings, exiting entirely with an estimated $58K sold.

  • 8 institutional investors held BioCardia (BCDA) as of Q3 2020, down from 12 in Q2 2020.
  • Funds reported $2.62M of BioCardia stock for Q3 2020, down 8% quarter-over-quarter.
  • 0 funds opened new BioCardia positions in Q3 2020 and 4 closed out, a net change of -4 holders.
  • The largest BioCardia buyer in Q3 2020 was Osaic Holdings, an estimated $6.52K added.
  • The largest BioCardia seller in Q3 2020 was CVI Holdings, an estimated $58K sold.

Based on aggregated 13F filings for Q3 2020.